How many institutions held PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value in Q4 2023?

15 institutional investors reported PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value for Q4 2023. Use the holders table for investor-level position and value details.

Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI)

Q: What does CUSIP 71678J209 represent in this 13F holders report?

CUSIP 71678J209 is the security identifier for PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 71678J209

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Common Stock, $0.0001 par value
Total 13F shares: 116,743
Total 13F value: $164,709
Share change: +17,137
SEC-reported price per share: $1.41
Number of holders: 15
Value change: +$20,587
Number of buys: 6
Number of sells: 2
Shares outstanding: 25,296,136

Security key

71678J209

Report period

Q4 2023

Institutions

Top holders

PTPI full security history Ownership snapshot Full 13F holder table Petros Pharmaceuticals, Inc. SEC filings Petros Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

John D. Shulman

Comparable rows

14/15

Latest evidence

30 Sep 2023

13F 3/4/5 Lead comparable stake: 0.13% 1 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 0.13%.

14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 0.13%

Schonfeld Strategic Advisors LLC 0.09%

BlackRock Finance, Inc. 0.07%

CITADEL ADVISORS LLC 0.06%

GEODE CAPITAL MANAGEMENT, LLC 0.04%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	0.13%	$55,030 31,811 shares	—	30 Sep 2023
Schonfeld Strategic Advisors LLC	13F Company 13F	0.09%	$39,268 22,700 shares	—	30 Sep 2023
BlackRock Finance, Inc.	13F Company 13F	0.07%	$28,561 16,510 shares	—	30 Sep 2023
CITADEL ADVISORS LLC	13F Company 13F	0.06%	$23,718 14,288 shares	—	30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.04%	$17,433 10,502 shares	—	30 Sep 2023
Tower Research Capital LLC (TRC)	13F Company 13F	0.01%	$4,398 2,542 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

116,743

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %